Community Research and Development Information Service - CORDIS


This booklet is intended to help citizens, patients, businesses and students to understand how the European Union (EU) promotes pharmaceutical trade and guarantees the quality, safety, and efficacy of medicinal products on the market in the 15 Member States. It also explains the pharmacovigilance mechanisms and the electronic communications network that have been put in place since the new Community system was established in 1995 to facilitate the dissemination of information on medicinal products, in particular between the Commission and national drug authorities.

Finally, it aims to familiarise those interested in pharmaceuticals and in the European Union with the new pharmaceutical marketing authorisation procedures that came into operation in 1995 and the decisions taken to improve the single market within the EU.

Additional information

Authors: DG for Enterprise, ;Pharmaceuticals and Cosmetics Unit,
Bibliographic Reference: Report, EURO:FREE of charge
Availability: Available from the European Commission, DG for Enterprise, Innovation, Communication and Awareness,Batiment Jean Monnet,Rue Alcide de Gasperi,L-2920,Luxembourg Office: EUFO 02/2295 Tel: +352 4301 33153 Fax: +352 4301 32084
ISBN: ISBN 92-828-9589-0
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top